Delivery Order SPE2DB22D3019-SPE2DB25FK4GA
Award Date 9/17/25
Potential Completion Date 9/18/25
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCL 4 mg, a pharmaceutical product commonly used for nausea and vomiting management. This firm fixed-price delivery order, valued at $25,849.82, was awarded on September 23, 2025, with an ultimate completion date of September 24, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a $9,434.26 delivery order to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCL 4 mg, a pharmaceutical product commonly used for nausea and vomiting management in medical settings. The contract is a firm fixed price delivery order with an ultimate completion date of August 13, 2025, and was awarded competitively with no set-aside designation. Performance will be executed from the awardee's location in Conshohocken, Pennsylvania, which serves as...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCL 4 mg, a commonly used anti-nausea medication. This firm fixed-price delivery order, valued at $8,642.13, was competitively awarded without set-aside provisions and is scheduled for completion by August 22, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a task under...
- The Defense Logistics Agency awarded a $18,664.07 delivery order to AmerisourceBergen Drug Corp for Ondansetron HCL 4 mg tablets (30-count units) with a completion date of September 11, 2025. This competitive award, issued as a firm fixed-price delivery order with no set-aside designation, represents a single transaction under AmerisourceBergen's larger contract vehicle with the agency. The pharmaceutical product will be delivered to the company's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCL 4 MG, with a ceiling value of $13,338.54 under a firm fixed-price contract type. The delivery order was competitively awarded without set-aside provisions and has an ultimate completion date of August 4, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCL 4 mg, a pharmaceutical product commonly used for nausea and vomiting management in clinical and military healthcare settings. Valued at $7,964.61 with a firm fixed price structure, this non-set-aside competitive award was executed on August 4, 2025, with an ultimate completion date of August 5, 2025. The contract represents a child order under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a $11,054.82 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for 500 tablets of Ondansetron HCl 4 mg, an anti-nausea medication commonly used in military and veteran healthcare settings. The contract carries a firm fixed price structure with no set-aside designation, indicating competitive award. Performance will be completed at AmerisourceBergen's Conshohocken, Pennsylvania facility, with an ultimate completion date of September 4,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Ondansetron ODT 4 mg, a commonly used anti-nausea medication, under a firm fixed-price contract valued at $1,842.70. The contract, which became effective on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order was competitively awarded...
- The Defense Logistics Agency awarded a $43,196.42 firm fixed price delivery order to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCl 4 mg, an anti-nausea medication commonly used in military and veteran healthcare settings. This non-set-aside contract, awarded on September 17, 2025, is scheduled for completion by September 18, 2025, with performance taking place at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. The award represents a child delivery order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of 500 tablets of Ondansetron HCL 4 mg at a ceiling value of $7,251.72. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and primary distribution hub for federal pharmaceutical...